Anheuser-Busch InBev SA/NV · BUD · FY2026 Q3 · Calendar Q4 2026
AB InBev posts strong Q3 growth as China weakness persists
AB InBev's Q3 analysis supports a constructive operating picture: premium brands, non-alcoholic and Beyond Beer products, and digital platforms are driving growth. The main counterweight is uneven geography, particularly China, alongside rising costs and investment needs.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about BUD FY2026 Q3
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior quarter, the supplied analysis shifts from reaffirmed EBITDA guidance and stable capex to no explicit Q3 guidance update, increasing capex, and a larger emphasis on the dividend increase and digital marketplace scale. China weakness became a more prominent risk, while non-alcoholic beer and Beyond Beer remained growth areas.
Guidance delta
No explicit Q3 guidance update was provided in the supplied analysis. The prior-quarter analysis cited maintained 2026 EBITDA growth guidance of 4–8%; the current analysis does not restate a new target.
Key takeaways
- Revenue and underlying EPS growth outpaced the prior year, supported by brand mix and premiumization.
- Soft-drink volume growth offset flat beer volumes, with China affected by weather and inventory pressures.
- Non-alcoholic beer and Beyond Beer are emerging growth engines, while BEES and D2C platforms continue to scale.
- The interim dividend increase and continued buyback program point to balance-sheet confidence, but sustainability remains an analyst concern.
Management priorities
- Invest in mega-brand platforms and premium brands.
- Accelerate BeatBox integration and commercial rollout.
- Expand digital D2C capabilities and third-party marketplace offerings.
- Scale non-alcoholic beer and RTD products globally.
Follow BUD with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| TD Cowen | Hold | Hold | Maintain | Oct 13, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Oct 5, 2026 |
| Barclays | Equal Weight | Overweight | Downgrade | Jul 27, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jul 2, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | May 7, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Feb 13, 2026 |
| Goldman Sachs | Buy | Neutral | Upgrade | May 12, 2025 |
| Citigroup | Buy | Neutral | Upgrade | Oct 1, 2024 |
| Exane BNP Paribas | Neutral | Outperform | Downgrade | Jan 12, 2024 |
| Jefferies | Buy | Hold | Upgrade | Jan 10, 2024 |
| B of A Securities | Buy | Neutral | Upgrade | Sep 29, 2023 |
| Deutsche Bank | Buy | Hold | Upgrade | Jun 22, 2023 |
| Redburn Partners | Buy | Neutral | Upgrade | Nov 19, 2021 |
| Argus Research | Hold | Buy | Downgrade | Sep 30, 2021 |
| CFRA | Hold | Hold | Maintain | May 26, 2020 |
| RBC Capital | Outperform | Sector Perform | Upgrade | Mar 12, 2020 |
| Credit Suisse | Neutral | Outperform | Downgrade | Mar 9, 2020 |
| Bryan Garnier | Neutral | Buy | Downgrade | Feb 28, 2020 |
| Redburn | Neutral | Sell | Upgrade | Nov 18, 2019 |
| UBS | Neutral | Buy | Downgrade | Aug 6, 2019 |
| Bank of America | Buy | Neutral | Upgrade | Jul 29, 2019 |
| Macquarie | Neutral | Neutral | Maintain | Mar 1, 2019 |
| Argus | Hold | Buy | Downgrade | Nov 12, 2018 |
| HSBC | Buy | Hold | Upgrade | Jun 4, 2018 |
| Bernstein | Outperform | Market Perform | Upgrade | Mar 12, 2018 |
| Investec | Hold | Buy | Downgrade | Nov 17, 2016 |
| Societe Generale | Hold | Buy | Downgrade | Oct 20, 2016 |
| Kepler Cheuvreux | Buy | Hold | Upgrade | Aug 22, 2016 |
| Susquehanna | Neutral | Positive | Downgrade | Aug 1, 2016 |
| Berenberg | Buy | Hold | Upgrade | Nov 13, 2015 |
| CLSA | Outperform | Underperform | Upgrade | Nov 2, 2015 |
| Ingalls & Snyder, LLC | Buy | Hold | Upgrade | Aug 26, 2015 |
| ING | Buy | Hold | Upgrade | Aug 26, 2015 |
| Stifel Nicolaus | Buy | Buy | Maintain | Jul 31, 2015 |
| Stifel | Buy | Buy | Maintain | Jul 31, 2015 |
| Nomura | Neutral | Buy | Downgrade | Jul 21, 2015 |
| Tigress Financial | Underperform | Neutral | Downgrade | Mar 17, 2015 |
| BTIG Research | Neutral | Buy | Downgrade | Sep 9, 2014 |
| BTIG | Neutral | Buy | Downgrade | Sep 9, 2014 |
| Rabobank | Buy | Hold | Upgrade | Jul 31, 2013 |
| Mirabaud Securities | Accumulate | Neutral | Upgrade | Jul 31, 2013 |
| Mirabaud | Accumulate | Neutral | Upgrade | Jul 31, 2013 |
| KBC Partners | Accumulate | Hold | Upgrade | Jul 31, 2013 |
| Canaccord Genuity | Buy | Hold | Upgrade | Jul 31, 2013 |
| Banco Sabadell | Sell | Buy | Downgrade | Apr 30, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $79.52. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Wells Fargo | Chris Carey | $97 | $86.14 | +22.0% | Jul 31, 2026 |
| Morgan Stanley | Analyst unavailable | $84.5 | $80.25 | +6.3% | Jul 1, 2026 |
| Morgan Stanley | Analyst unavailable | $82 | $74.39 | +3.1% | Apr 8, 2026 |
| Evercore ISI | Analyst unavailable | $100 | $79.4 | +25.8% | Feb 13, 2026 |
| Wells Fargo | Analyst unavailable | $85 | $75.81 | +6.9% | Feb 9, 2026 |
| Wells Fargo | Analyst unavailable | $75 | $61.16 | -5.7% | Nov 19, 2025 |
| Jefferies | Edward Mundy | $74 | $59.85 | -6.9% | Sep 29, 2025 |
| Argus Research | Analyst unavailable | $70 | $62.14 | -12.0% | Mar 27, 2025 |
| Morgan Stanley | Sarah Simon | $63 | $49.22 | -20.8% | Jan 9, 2025 |
| Morgan Stanley | Sarah Simon | $73 | $63.66 | -8.2% | Sep 10, 2024 |
| Morgan Stanley | Sarah Simon | $68.5 | $59.96 | -13.9% | Apr 8, 2024 |
| Barclays | Eddie Kim | $65 | $60.2 | -18.3% | Mar 5, 2024 |
| Jefferies | Edward Mundy | $76 | $66.15 | -4.4% | Jan 10, 2024 |
Track every rating change on BUD the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationAnheuser-Busch InBev SA/NV (AB InBev) is a global beverage giant involved in the manufacturing, marketing, and retailing of a wide variety of beers, other alcoholic drinks, and soft drinks across the world. The company manages an expansive collection of around 500 beer labels. Its most prominent and globally recognized brands include Budweiser, Corona, and Stella Artois. Additionally, its portfolio features well-known names such as Beck's, Hoegaarden, Leffe, and Michelob Ultra, alongside a host of other popular brands like Aguila, Antarctica, Bud Light, Brahma, Cass, Castle, Castle Lite, Cristal, Harbin, Jupiler, Modelo Especial, Quilmes, Victoria, Sedrin, and Skol. Established in 1366, AB InBev's corporate headquarters are situated in Leuven, Belgium.
Consumer Defensive peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| ABEV Ambev S.A. | FY2026 Q3 · Calendar Q4 2026 | — | -4.0% | Ambev Q3: Growth Holds, Digital Platforms Accelerate |
| HSY The Hershey Company | FY2026 Q3 · Calendar Q4 2026 | — | -1.8% | Hershey maintains 2027 growth outlook as innovation expands |
| BG Bunge Global S.A. | FY2026 Q3 · Calendar Q4 2026 | — | -3.1% | Bunge Maintains 2026 EPS Guidance as Projects Advance |
Latest beats and misses
Who reports nextBeat on EPS
- HIIFY2026 Q3 · October 29, 2026+25.7% EPS+13.2% move
- KIM-PNFY2026 Q3 · October 29, 2026+101.6% EPS— move
- FLSFY2026 Q3 · October 28, 2026+9.0% EPS+11.9% move
- ENTGFY2026 Q3 · October 29, 2026+19.4% EPS+0.4% move
- WCCFY2026 Q3 · October 29, 2026+23.0% EPS+5.6% move
- ASXFY2026 Q3 · October 29, 2026+8.8% EPS+1.4% move
Missed on EPS
- SCIFY2026 Q3 · October 28, 2026-2.1% EPS-8.7% move
- AMFY2026 Q3 · October 28, 2026-5.6% EPS+3.7% move
- INGFY2026 Q3 · October 29, 2026-5.1% EPS-2.0% move
- AMPFY2026 Q3 · October 29, 2026-4.3% EPS+1.7% move
- AMRZFY2026 Q3 · October 28, 2026-1.0% EPS+3.9% move
- MAAFY2026 Q3 · October 28, 2026-5.9% EPS+1.3% move
Get the BUD recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-10-29T18:10:02.843913+00:00
- FN2 earnings calendar · 2026-10-30T01:23:13.979536+00:00
- Polygon adjusted daily market bars · 2026-10-30T03:10:42.380785+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-30T03:10:42.378168+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-30. For educational purposes only; not investment advice.